↑
Skip links

Proven performance of domestic AI low-dose CT technology

2022-09-21

Proven performance of domestic AI low-dose CT technology

【Welfare News】 The artificial intelligence low-dose CT technology developed in Korea is attracting attention as its performance has been proven in multinational clinical trials for the first time.

×

New Partnerships at ClariPi

Jul 27, 2023

ConcertAI’s TeraRecon Partners with ClariPi

https://www.prnewswire.com/news-releases/concertais-terarecon-partners-with-claripi-to-integrate-ai-solutions-for-comprehensive-medical-imaging-on-eureka-clinical-ai-platform-301886649.html

ClariPi Joins Siemens Healthineers Digital Marketplace

https://www.prnewswire.com/news-releases/claripi-joins-siemens-healthineers-digital-marketplace-301685732.html?tc=eml_cleartime

https://marketplace.teamplay.siemens-healthineers.com/apps

ClariPi’s Joins Bayer’s Calantic – Breast Density Measurement Solution 

https://www.bayer.com/media/en-us/bayer-advances-radiology-development-portfolio-and-fosters-innovation-in-ai/

Contact Us

ClariPi will be at KCR in Seoul, Korea!

Sep 20, 2023 - Sep 23, 2023
Seoul, South Korea

ClariPi will be at KCR from Sept. 20 – 23, 2023 at Coex, Seoul, Korea–Booth number S-01 (1st Floor, B Hall). If you are interested in our products, you could visit our booth or arrange a demo session online. Just message us to schedule a meeting! Thank you!

*KCR 2023 Luncheon Symposium (Location: Auditorium 3F, LS-02): Click Here

 

 

Click Here to find out more! Request A Meeting